Biotech News
Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference
ir.fulgentgenetics.com2026-05-06 15:27 EST
EL MONTE, Calif.--(BUSINESS WIRE)--Oct. 20, 2025-- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced preliminary clinical data as of September